Considering that the current subtypes of breast cancer, especially TNBC and HER2+, still have some limitations in prognosis prediction and treatment, we would like to propose a new concept that combined prognostic cells with existing subtype classification of patients may assist more effective prediction methods and treatment guideline of breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.